Deputy Editor-in-Chief, Sanhu Wang, GJO

Sanhu Wang, MD

  1. Distinguished Expert
    Bao’an District Traditional Chinses Medicine (TCM) Hospital
    Shenzhen, China
  2. The Chief TCM Expert on Oncology
    Xi’an TCM Hospital and Weinan Central TCM Hospital.
  3. Doctoral Supervisor
    California University of TCM
    California, USA.
  4. Emeritus Professor
    Sichuan Military Medical University
  5. Famous Distinguished TCM Doctor in Shaanxi and Guangxi Provinces
  6. Deputy Chairman, the Jing Fang Tumor Treatment Professional Committee of the World Federation of TCM.
  7. Advisor, European Jing Fang Society.
  8. Advisor, TCM Society of the Chinese People in Switzerland.
  9. Awarded of TCM People with Strongest Influences in 2017.

Professor Sanhu Wang has adhered to the idea of combining the theory with practice and focused on inheritance and innovation of TCM for many years. He has proposed many new viewpoints such as “mixed dryness and dampness resulting in cancer”, “bonded chill and fever resulting in cancer”, “deepened pathogenic viruses enabling tumors to form”, “anticancer function of ginseng”, “anticancer function of keeping the roots”, and “diagnosis and treatment of lung cancer as the consumptive lung disease”. Many of his viewpoints have been published in journals, newspapers, textbooks and guidelines. He has published over 230 papers. He has compiled and participated in the compilation of over 30 books, including 5 best-seller books.
Professor Sanhu Wang has successively recruited and educated over 100 master’s degree candidates and apprentices. In recent years, he has successfully held multiple Jing Fang-based anticancer training classes in China and foreign countries. Jing Fang-based Anticancer Series Courses of TCM Online has been listed among the Ten Excellent Books and Courses of TCM in 2017. He has established Jing Fang-based anticancer workstations in some places such as Xi’an, Shenzhen, Zibo, Taizhou and Jiamusi.
Professor Sanhu Wang is a distinguished expert on treating many kinds of tumors and treats annually about 20,000 domestic and foreign patient-times.